53

Lykis LtdBOM 530689 Stock Report

Last reporting period 31 Mar, 2024

Updated 31 Oct, 2024

Last price

Market cap $B

0.005

Micro

Exchange

XBOM - Bombay Stock Exchange

530689.BO Stock Analysis

53

Avoid

Based on Eyestock quantitative analysis, 530689.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

40/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-17.8 %

Overvalued

Market cap $B

0.005

Dividend yield

Shares outstanding

19.38 B

Lykis Ltd. is a home and personal care company. The company is headquartered in Mumbai, Maharashtra. The Company’s presence spans across the beauty and grooming segment, homecare segment, food, and beverages segment, and health, and wellbeing segment. These include a portfolio of brand names, such as Lykis, Britex, Rox, Bonita, Vogly, Tazaagi, and Alivio. Its personal care products include personal wash, hair care, deodorants, perfumes, talcum, skincare, and baby care products. The Company’s home care products include dish wash bar and liquid, floor cleaner, glass cleaner, toilet cleaner and air freshener. The Company’s food and confectionery products include biscuits, candies, lollipops, and snacks. Its over the counter (OTC) products include Act pain relief ointment, Davimov cream, Davimov balm and Cold grip inhaler. The company has operation comprises in 36 countries including African countries, Commonwealth of Independent States (CIS) countries, United States of America, United Kingdom, and Haiti & Middle East countries.

View Section: Eyestock Rating